According to the FDA, the following companies have allegedly sold the following unapproved and/or misbranded new drugs. If you are in possession of any of the below drugs, please contact Audet & Partners, LLP to protect your legal rights.
- Roxanol Oral Solution, 20 mg/ml;
- Roxicodone Tablets, 5 mg
- Morphine Sulfate Solution Immediate Release 20mg/ml
- Morphine Sulfate Tablets, 15 mg & 30 mg;
- Morphine Sulfate Solution Immediate Release Concentrate, 20 mg/ml;
- Morphine Sulfate Solution Immediate Release Oral Solution, 20mg/5ml
- Morphine Sulfate Solution Immediate Release Concentrate, 20 mg/ml;
- Hydromorphone HCI Tablets, 2mg and 4mg
- Morphine Sulfate Tablets, 15 mg & 30 mg;
- Morphine Sulfate Solution Concentrate, 20 mg/ml;
- Morphine Sulfate Concentrate Oral Solution 20mg/ml
- Morphine Sulfate Immediate Release Tablets, 30 mg;
- Hydromorphone Tablets, 2 mg;
- Hydromorphone Hydrochloride Tablets 4 mg
- Hydromorphone Hydrochloride Tablets, 2 mg & 4 mg
- Roxanol Oral Solution, 20 mg/ml;
- Roxicodone Tablets, 5 mg
Audet & Partners represents individuals, governmental entities, small businesses and institutional shareholders in product liability, tort, negligence, consumer, construction defect, investment fraud, securities, insider trading, antitrust, environmental, whistle blower, aviation and employment cases. In recognition of their outstanding abilities and commitment to the legal profession over the years, the firm and its members have served as Court-appointed Plaintiffs’ Counsel in dozens of federal and state cases throughout the United States.
